Covid und Long-Covid — Evidenz und Therapeutische Erfahrung in der Behandlung Mit Chinesischer Medizin  <span class="so-article-trans-title" dir="auto"> Translated title: COVID and Long COVID — Evidence and Therapeutic Experience in Treatment With Chinese Medicine </span>

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

COVID-19 — ein Begriff, der die letzten beiden Jahre stark geprägt hat und es noch immer tut. Aber wie entwickeln sich die Therapiemethoden auf dem Gebiet der Behandlung dieser Erkrankung? Viel Forschung wird betrieben. Sowohl auf dem Gebiet der klassischen Schulmedizin als auch im Bereich der integrativen Medizin. Schon jetzt zeigt sich klar der Benefit, den die zusätzliche Behandlung mit CM ergibt.

Translated abstract

COVID-19 — a term who had and still has a great impact on us in the last two years. But how is the development according to treatments for this disease? There’s a lot of research going on, in classical school medicine and in the integrative field. It’s already clear that there’s a huge benefit resulting from the additionally treatment with CM.

Related collections

Most cited references 4

Record: found
Abstract: found
Article: not found

Complementary and alternative medicine (CAM) interventions for COVID-19: An overview of systematic reviews

Sae-Rom Jeon, Jung Won Kang, Lin Ang … (2022)

Background Since the beginning of the Coronavirus disease 2019 (COVID-19) pandemic, various complementary and alternative medicines (CAMs) have been used in clinical practice. In this overview, we summarized the evidence for CAM interventions in the treatment of COVID-19 patients. Methods For this overview, PubMed, Embase and Cochrane Library were searched from inception to October 2021. Systematic reviews (SRs) on the effectiveness and safety of CAM interventions for COVID-19 patients were located, and the MeaSurement Tool to Assess Systematic Reviews 2 (AMSTAR 2) was used to evaluate the reporting quality of the included SRs. Keywords including COVID-19 and CAM interventions were used for locating SRs. For evidence mapping, we created a two-dimensional bubble plot that included the width and strength of the evidence for each CAM intervention and specific outcome. Results In this overview, we identified 24 SRs (21 for traditional Chinese Medicine (TCM) medications, two for vitamin D and one for home-based activity). From the included SRs, TCM herbal medications were reported to show good results in decreasing the rate of disease progression (relative risk (RR) 0.30, 95% confidence intervals (CI) [0.20, 0.44]), time to the resolution of fever (standard mean difference (SMD) -0.98, 95% CI [-1.78, -0.17]) and rate of progression to severe COVID-19 cases (RR 0.34, 95% CI [0.18, 0.65]), but the evidence for other interventions did not show effectiveness with certainty. Gastric disturbance was a major adverse event of TCM medications. Conclusion There is evidence that TCM medications are effective in the symptom management of COVID-19 patients. However, evidence for the effectiveness of most CAM interventions still needs evaluation.

0 comments Cited 15 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: found

Is Open Access

Acupuncture in Multidisciplinary Treatment for Post-COVID-19 Syndrome

Robert J. Trager, Elise Brewka, Christine Kaiser … (2022)

Background: Post-COVID syndrome (PCS) is a complex, multisystem illness that may follow SARS-CoV-2/COVID-19 infection. As there is limited evidence for individual therapies and no singular treatment for PCS, guidelines endorse a multidisciplinary approach. This is a case report of a patient with PCS benefiting from a comprehensive approach including acupuncture with symptom-titrated physical activity (STPA). Case: A 50-year-old woman presented from a Long-COVID Clinic referral to an outpatient hospital-affiliated acupuncturist. She had 8 months of fatigue, anosmia, chest pressure, palpitations, and other symptoms following mild assay-confirmed COVID-19. Prior/concurrent medical testing revealed multisystem-inflammatory involvement (pericardial effusion, thyroid dysfunction, and elevated d-dimers). Cardiology/pulmonology cleared the patient for exercise to tolerance considering that serious pathology was absent. The acupuncturist's Traditional Chinese Medicine impression was of Qi Deficiency of the Heart, Lung, Spleen, and Kidney. This patient received 7 sessions of scalp, auricular, and body acupuncture. Physical-therapist (PT)-led STPA began 1-week post-acupuncture, involving 6 30-minute exercise sessions while monitoring her heart rate, with as-needed rest. Results: The patient's chest pressure and palpitations resolved after 1 acupuncture treatment. With 6 additional treatments, spanning 9 weeks, overlapping with PT-led SPTA, she recovered completely and resumed her normal exercise. Conclusions: Acupuncture appeared to facilitate PCS recovery. However, the independent effects of acupuncture are less clear, given the concurrent STPA/exercise therapy, and should be explored using large study designs. Acupuncture is an attractive potential PCS therapy, considering its holistic approach and that it may be added to a multidisciplinary, guideline-concordant regimen.

0 comments Cited 11 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A Scoping Review

Mengjuan Ren, Yunlan Liu, Xiaojia Ni … (2022)

Introduction This study aims to summarize the available evidence and guideline/consensus recommendations for acupuncture and moxibustion in the treatment, prevention and rehabilitation of patients with coronavirus disease 2019 (COVID-19). Methods A scoping review was performed. Eight electronic databases and other related websites were searched. All studies related to acupuncture and moxibustion for COVID-19 were considered. Descriptive analysis was applied to analyze the all included studies and guideline recommendations. Results We ultimately included 131 eligible studies. The main topics of the included studies were the treatment (82.4%) and prevention (38.9%) of COVID-19. The most included studies were literature reviews (65, 49.6%), protocols of systematic reviews (20, 15.3%), and guidelines/guidance and consensuses (18, 13.7%). The 18 (13.7%) COVID-19 guidelines and consensuses included 47 recommendations on acupuncture and moxibustion, which focused on the treatment (21/47, 44.7%), rehabilitation (17/47, 36.2%) and prevention (6, 12.8%) of COVID-19 patients. Zusanli (ST36), Feishu (BL13), Guanyuan (RN4) were recommended mostly for the treatment, rehabilitation and prevention respectively. Conclusion Acupuncture and moxibustion are effective in the treatment of COVID-19 patients to some extent. However, more high-quality of clinical trials still needed to determine the feasibility of acupuncture and moxibustion in COVID-19 patients to better guide clinical practice. Study registration Open Science Framework (DOI: 10.17605/OSF.IO/Z35WN).

0 comments Cited 9 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Contributors

Eva Schönhart: http://www.tcmpraxis-graz.at

Bio :

Dr. med. Eva Schönhart

Ärztin für Allgemeinmedizin & CM Mariatroster Strasse 190 A-8044 Graz www.tcmpraxis-graz.at

Journal

Journal ID (iso-abbrev): Akupunkt Aurikulomed

Title: Akupunktur & Aurikulomedizin

Publisher: Springer Medizin (Heidelberg )

ISSN (Print): 2192-9319

ISSN (Electronic): 2196-6400

Publication date (Electronic): 12 December 2022

Publication date (Print): 2022

Volume: 48

Issue: 4

Pages: 42-45

Affiliations

Mariatroster Strasse 190, A-8044 Graz, Austria

Article

Publisher ID: 5815

DOI: 10.1007/s15009-022-5815-9

PMC ID: 9772587

SO-VID: 99e6a103-63e4-4ad7-a1f3-4e27897e3ced

License:

This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

History

Custom metadata

Keywords: sars-cov-2,long-covid,post-covid,zytokin-sturm,pestilenz-qi,cytokin storm,pestilence-qi

Data availability:

Keywords: sars-cov-2, long-covid, post-covid, zytokin-sturm, pestilenz-qi, cytokin storm, pestilence-qi

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Most referenced authors 20

See all reference authors

Covid und Long-Covid — Evidenz und Therapeutische Erfahrung in der Behandlung Mit Chinesischer Medizin Translated title: COVID and Long COVID — Evidence and Therapeutic Experience in Treatment With Chinese Medicine

Read this article at

Abstract

Translated abstract

Related collections

Novel Coronavirus Disease COVID-19

Most cited references 4

Complementary and alternative medicine (CAM) interventions for COVID-19: An overview of systematic reviews

Acupuncture in Multidisciplinary Treatment for Post-COVID-19 Syndrome

The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A Scoping Review

Author and article information

Contributors

Journal

Affiliations

Article

History

Categories

Custom metadata

Comments

Comment on this article

Similar content 310

Most referenced authors 20